SCHEMBL21905511

SCHEMBL21905511

c1ccc(-c2ccc(-c3ccc(Nc4ccc(-n5c6ccccc6c6ccccc65)cc4)cc3)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.59
KDM4E B2RXH2 2/20 0.59
ATM Q13315 1/20 0.59
HDAC4 P56524 1/20 0.49
EPHX2 P34913 1/20 0.41
ALDH1A1 P00352 5/20 0.41
HSD17B10 Q99714 3/20 0.41
ALOX15 P16050 2/20 0.41
TSHR P16473 2/20 0.41
ALOX12 P18054 2/20 0.41
PTGS1 P23219 1/20 0.41
SLC6A2 P23975 1/20 0.41
MAPK1 P28482 1/20 0.41
PTGS2 P35354 1/20 0.41
HTR2B P41595 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
KMT2A Q03164 4/20 0.41
IL1R1 P14778 1/20 0.41
PTPN1 P18031 2/20 0.40
MEN1 O00255 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30327370 1.00 L3MBTL1 (0.59) L3MBTL1KDM4EATMHDAC4EPHX2
SCHEMBL12249880 1.00 L3MBTL1 (0.59) L3MBTL1KDM4EATMHDAC4EPHX2
SCHEMBL30151523 1.00 L3MBTL1 (0.59) L3MBTL1KDM4EATMHDAC4EPHX2
SCHEMBL30659225 1.00 L3MBTL1 (0.59) L3MBTL1KDM4EATMHDAC4EPHX2
SCHEMBL23423503 1.00 L3MBTL1 (0.59) L3MBTL1KDM4EATMHDAC4EPHX2
SCHEMBL23310448 1.00 L3MBTL1 (0.59) L3MBTL1KDM4EATMHDAC4EPHX2
SCHEMBL31018940 1.00 L3MBTL1 (0.59) L3MBTL1KDM4EATMHDAC4EPHX2
SCHEMBL23423507 1.00 L3MBTL1 (0.59) L3MBTL1KDM4EATMHDAC4EPHX2
SCHEMBL15713398 1.00 L3MBTL1 (0.59) L3MBTL1KDM4EATMHDAC4EPHX2
SCHEMBL30619279 1.00 L3MBTL1 (0.59) L3MBTL1KDM4EATMHDAC4EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11991926-B2 Organic electroluminescent device LG DISPLAY CO., LTD. (KR) 2024-05-21 US disclosed
US-11744145-B2 Organic compound and organic electroluminescent device comprising the same LG DISPLAY CO., LTD. (KR) 2023-08-29 US disclosed
US-11744145-B2 Organic compound and organic electroluminescent device comprising the same LG DISPLAY CO., LTD. (KR) 2023-08-29 US disclosed
US-11744145-B2 Organic compound and organic electroluminescent device comprising the same LG DISPLAY CO., LTD. (KR) 2023-08-29 US disclosed
US-11545630-B2 Compound and organic electroluminescent device comprising the same LG DISPLAY CO., LTD. (KR) 2023-01-03 US disclosed
US-11545630-B2 Compound and organic electroluminescent device comprising the same LG DISPLAY CO., LTD. (KR) 2023-01-03 US disclosed
US-20210159422-A1 Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2021-05-27 US disclosed
US-20200335705-A1 ORGANIC ELECTROLUMINESCENT DEVICE LG DISPLAY CO., LTD. (KR) 2020-10-22 US disclosed
US-20200335705-A1 ORGANIC ELECTROLUMINESCENT DEVICE LG DISPLAY CO., LTD. (KR) 2020-10-22 US disclosed
US-20200144509-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME MATERIAL SCIENCE CO., LTD. (KR) 2020-05-07 US disclosed
US-20200144506-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME MATERIAL SCIENCE CO., LTD. (KR) 2020-05-07 US disclosed
US-20200144506-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME MATERIAL SCIENCE CO., LTD. (KR) 2020-05-07 US disclosed
US-20200144509-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME MATERIAL SCIENCE CO., LTD. (KR) 2020-05-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11545630-B2 Compound and organic electroluminescent device comprising the same PIEZO1, KCNN2, ORAI2 L3MBTL1 467/4885KDM4E 1244/4885ATM 3340/4885
US-20210159422-A1 Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device ARNT, SUN2, AHR L3MBTL1 337/4885KDM4E 3263/4885ATM 3759/4885
US-20200144509-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME PIEZO1, KCNN2, HCN2 L3MBTL1 504/4885KDM4E 1210/4885ATM 3220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.